Abstract
We searched for serum concentrations of trace elements and correlated them to malondialdehyde (MDA), which is an indirect marker of oxidative stress, in order to clarify if routine evaluation is necessary in chronic obstructive pulmonary disease (COPD) outpatients. Serum concentrations of copper (Cu), zinc (Zn), and magnesium (Mg) were determined by atomic absorption spectrophotometry and iron (Fe) by a ILLab 1800 autoanalyzer with ILLab test kits. Serum MDA concentrations were detected in terms of TBARS (thiobarbituric acid reactive substances) spectrophotometrically.
Serum Cu, Zn, Mg, Fe, and MDA concentrations in patient and control groups were all in the normal reference range. The results respectively were as follows: Cu:123±29.2 and 122.2±23.4 µg/dL; Zn: 87.8±17.8 and 96.9 ± 12.9 µg/dL; Mg: 2.3±0,5 and 2.04±0.28 mg/dL; Fe: 73.8±35.5 and 80.7±51.2 µg/dL; MDA: 1.09±0.11 and 0.95±0.06 nmol/L. MDA was not correlated to Cu, Zn, Mg, or Fe (p>0.05 for all). The serum Zn concentration of COPD group was lower than the control group (p=0.042), whereas the Mg concentration was higher (p=0.021). There was no statistical difference in other study parameters. Oxidative stress was not increased in clinically stable, regularly treated COPD patients. Although there was no deficiency in trace elements (Cu, Fe, Mg, and Zn), serum Zn was close to the lower limit of the reference value. There is no need for routine evaluation of trace elements in clinically stable, regularly treated COPD outpatients.
Similar content being viewed by others
References
Y. L. Huang, J. Y. Sheu, and T. H. Lin, Association between oxidative stress and changes of trace elements in patients with breast cancer, Clin. Biochem. 32(2), 131–136 (1999).
R. A. Floyd, Role of oxygen free radicals in carcinogenesis and brain ischemia, FASEB J. 4, 2587–2597 (1990).
J. M. Gutteridge and B. Halliwell, Antioxidants in Nutrition, Health and Disease, Oxford University Press, Oxford (1994).
I. Yucel, F. Arpaci, A. Ozet, et al., Serum copper and zinc concentrations and copper/zinc ratio in patients with breast cancer, Biol. Trace Element Res. 40, 31–38 (1994).
American Thoracic Society, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152, 77–120 (1995).
American Thoracic Society, Standardization of spirometry. Am. J. Respir. Crit. Care Med. 152, 1107–1136, (1995).
J. A. Buege and S. D. Aust, Microsomal lipid peroxidation, Methods Enzymol. 52, 302–310 (1978).
J. Arnaud, P. Chappuis, R. Zawislak, et al., Comparison of serum copper determination by colorimetric and atomic absorption spectrometric methods in seven different laboratories. The S.F.B.C. (Societe Francaise de Biologie Clinique) Trace Element Group, Clin. Biochem. 26(1), 43–49 (1993).
H. T. Delves, F. W. Alexander, and H. Lay, Copper and zinc concentrations in the plasma of leukemic children, Br. J. Haematol. 24, 525 (1973).
J. B. Willis, The determination of metals in blood serum by atomic absorption spectroscopy 2 (Magnesium), Spectrochim. Acta 16, 273 (1960).
M. M. Parker, F. L. Humaller, and D. J. Mahler, Determination of copper and zinc in biological material, Clin. Chem. 13(1), 40 (1967).
J. Schwartz and S. T. Weiss, Dietary factors and their relation to respiratory symptoms, Am. J. Epidemiol. 192(1), 67–76 (1990).
A. Molteni, W. Ward, Y. T. Kim, et al., Serum copper concentration as an index of clinical lung injury, Adv. Exp. Med. Biol. 258, 273–285 (1989).
E. S. Lebedeva, F. S. Tadzhiev, L. N. Danilov, et al., Content of trace elements and steroid hormones in blood and tissues of internal organs of rats during an inflammatory process in the bronchi, Patol. Fiziol. Eksp. Ter. 3, 3–5 (1992).
F. S. Tadzhiev, Trace elements in the pathogenesis and treatment of chronic bronchitis (a clinico-experimental study), Ter. Arkh. 63(3), 68–70 (1991).
M. T. Leon-Espinosa de los Monteros, B. Gil Extremera, A. Maldonado Martin, et al., Zinc and chronic obstructive pulmonary disease, Rev. Clin. Esp. 200(12), 649–653 (2000).
E. Kurys, P. Kurys, A. Kuzniar, et al., Analysis of antioxidative enzyme activity and magnesium concentration in chronic obstructive pulmonary disease, Ann. Univ. Mariae Curie Sklodowska (Med). 56, 261–266 (2001).
M. S. Skorodin, M. F. Tenholder, B. Yetter, et al., Magnesium sulphate in exacerbations of chronic obstructive pulmonary disease, Arch. Intern. Med. 155(5), 496–500 (1995).
B. Halliwell and J. M. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol. 186, 1–85 (1990).
I. Rahman, D. Morrison, K. Donaldson, et al., Systemic antioxidative stress in asthma, COPD and smokers, Am. J. Respir. Crit. Care Med. 154, 1055–1060 (1996).
D. Morrison, I. Rahman, S. Lannan, et al., Epithelial permeability, inflammation, and oxidative stress in the air spaces of smokers, Am. J. Crit. Care Med. 159, 473–479 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karul, A.B., Karadag, F., Yensel, N. et al. Should chronic obstructive pulmonary disease outpatients be routinely evaluated for trace elements?. Biol Trace Elem Res 94, 41–47 (2003). https://doi.org/10.1385/BTER:94:1:41
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:94:1:41